The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bykova A.A.

GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova"

Dumikian A.Sh.

Sechenov First Moscow State Medical University

Azizova O.A.

GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova";
FGBUN "Nauchno-issledovatel'skiĭ institut fiziko-khimicheskoĭ meditsiny Federal'nogo mediko-biologicheskogo agentstva", Moskva

Aseĭchev A.V.

FGBUN "Nauchno-issledovatel'skiĭ institut fiziko-khimicheskoĭ meditsiny Federal'nogo mediko-biologicheskogo agentstva", Moskva

Sergienko V.I.

FGBUN "Nauchno-issledovatel'skiĭ institut fiziko-khimicheskoĭ meditsiny Federal'nogo mediko-biologicheskogo agentstva", Moskva

Syrkin A.L.

Sechenov First Moscow State Medical University

Prognostic value of myeloperoxidase on patient with acute coronary syndrome

Authors:

Bykova A.A., Dumikian A.Sh., Azizova O.A., Aseĭchev A.V., Sergienko V.I., Syrkin A.L.

More about the authors

Views: 1300

Downloaded: 35


To cite this article:

Bykova AA, Dumikian ASh, Azizova OA, Aseĭchev AV, Sergienko VI, Syrkin AL. Prognostic value of myeloperoxidase on patient with acute coronary syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(4):4‑10. (In Russ.)

Recommended articles:
Clinical, demo­graphic, anamnestic and instrumental data of patients with acute coro­nary syndrome and Covid-19. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):204-209

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.